Swiss equity markets dip, but Roche and Swiss Re thrive—discover how reimbursement reforms, digital health ROI, and cost‑saving strategies keep Swiss healthcare resilient.
Smith & Ne phew plc redeems its 5.150 % notes due 2027 on Oct 5, 2026, paying principal plus a modest premium to note holders—boosting debt ratios and future EBIT.
Explore Philips’ AI‑enabled ultrasound platform: how it boosts imaging throughput, cuts costs, and drives market growth for medical imaging tech investors.
Centene insider stock buys reveal execs’ commitment to value‑based care, tech investment and stronger shareholder alignment. Gain insights on how this shapes future strategy.
Carvolix boosts leadership, secures €40 m capital, and advances its TAVIPILOT platform to CE and FDA filing, aiming to expand global heart‑tech adoption and improve patient outcomes.
Kingfish Limited reports a slight NAV drop to $1.2608, narrowing its discount and spotlighting Fisher & Paykel as the top holding for growth and dividends.
Discover how Siemens Healthineers blends AI‑driven imaging, resilient margins, and strategic reimbursement wins to stay a top player in German healthcare and DAX stability.
Fresenius SE faces a steep FDA warning letter over GMP violations, prompting a 6% share drop and potential U.S. application holds—what this means for investors and competitors.
European markets edge up on easing Middle East tensions and falling oil, yet healthcare names like Fresenius Medical Care face cautious investor sentiment, highlighting sector‑specific risks amid volatile macro‑economic conditions.